A Provider's Guide to Vascular Disease, Dyslipidemia, and Glycemic Dysregulation in Chronic Spinal Cord Injury

Area of Science:

• Neurology
• Cardiology
• Endocrinology

Background:

• Chronic spinal cord injury (SCI) is linked to increased risks of accelerated atherogenesis, dyslipidemia, and glycemic dysregulation.
• The etiologies and clinical consequences of these secondary effects of paralysis are not fully understood.
• Recent guidelines address cardiometabolic disease in SCI, but data-driven approaches have been historically limited.

Purpose of the Study:

• To summarize current knowledge on cardiovascular disease and glycemic dysregulation in individuals with SCI.
• To identify gaps in understanding regarding the causes and impacts of these conditions.
• To review existing and informal recommendations for managing cardiometabolic health in SCI.

Main Methods:

• Literature review of existing studies on SCI and cardiometabolic disease.
• Analysis of current clinical guidelines and informal recommendations.
• Synthesis of known and unknown factors related to cardiovascular and glycemic health post-SCI.

Main Results:

• Individuals with SCI exhibit a predisposition to conditions like atherosclerosis and diabetes.
• Significant knowledge gaps persist concerning the underlying mechanisms and long-term health outcomes.
• A review of both guideline-based and anecdotal clinical care strategies is presented.

Conclusions:

• There is a clear need for more research into the cardiometabolic complications of SCI.
• Current management strategies should integrate guideline-driven and evidence-based informal recommendations.
• Addressing cardiovascular disease and glycemic dysregulation is crucial for improving the health of individuals with SCI.